119 related articles for article (PubMed ID: 8519439)
1. Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine.
Jaatinen P; Riihioja P; Haapalinna A; Heinonen E; Kiianmaa K; Hervonen A
Alcohol; 1995; 12(5):439-46. PubMed ID: 8519439
[TBL] [Abstract][Full Text] [Related]
2. Reactions of rat sympathetic neurons to ethanol exposure are age-dependent.
Jaatinen P; Hervonen A
Neurobiol Aging; 1994; 15(4):419-28. PubMed ID: 7969718
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexmedetomidine on rat locus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure.
Riihioja P; Jaatinen P; Haapalinna A; Kiianmaa K; Hervonen A
Alcohol Clin Exp Res; 1999 Mar; 23(3):432-8. PubMed ID: 10195815
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat.
Riihioja P; Jaatinen P; Oksanen H; Haapalinna A; Heinonen E; Hervonen A
Alcohol Clin Exp Res; 1997 Aug; 21(5):804-8. PubMed ID: 9267529
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat.
Riihioja P; Jaatinen P; Oksanen H; Haapalinna A; Heinonen E; Hervonen A
Alcohol; 1997; 14(6):537-44. PubMed ID: 9401667
[TBL] [Abstract][Full Text] [Related]
6. Alpha 2-adrenoceptor agonist, dexmedetomidine, protects against kainic acid-induced convulsions and neuronal damage.
Halonen T; Kotti T; Tuunanen J; Toppinen A; Miettinen R; Riekkinen PJ
Brain Res; 1995 Sep; 693(1-2):217-24. PubMed ID: 8653412
[TBL] [Abstract][Full Text] [Related]
7. Effects of continuous versus intermittent ethanol exposure on rat sympathetic neurons.
Riikonen J; Jaatinen P; Karjala K; Rintala J; Pörsti I; Wu X; Eriksson CJ; Hervonen A
Alcohol Clin Exp Res; 1999 Jul; 23(7):1245-50. PubMed ID: 10443993
[TBL] [Abstract][Full Text] [Related]
8. Lifelong ethanol consumption enhances the age-related changes in rat sympathetic neurons.
Jaatinen P; Kiianmaa K; Hervonen A
Mech Ageing Dev; 1992 Apr; 63(2):193-205. PubMed ID: 1351124
[TBL] [Abstract][Full Text] [Related]
9. Ethanol antagonism by atipamezole on motor performance in mice.
Seppälä T; Idänpään-Heikkilä JJ; Strömberg C; Mattila MJ
Life Sci; 1994; 55(3):245-51. PubMed ID: 7911966
[TBL] [Abstract][Full Text] [Related]
10. Ethanol-induced vacuolation in rat peripheral nervous system.
Jaatinen P; Kiianmaa K; Lahtivirta S; Hervonen A
J Auton Nerv Syst; 1994; 46(1-2):107-21. PubMed ID: 7907099
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of an alpha 2 adrenergic agonist desensitizes rats to the anesthetic effects of dexmedetomidine.
Reid K; Hayashi Y; Guo TZ; Correa-Sales C; Nacif-Coelho C; Maze M
Pharmacol Biochem Behav; 1994 Jan; 47(1):171-5. PubMed ID: 7906889
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase B inhibitor selegiline protects young and aged rat peripheral sympathetic neurons against 6-hydroxydopamine-induced neurotoxicity.
Salonen T; Haapalinna A; Heinonen E; Suhonen J; Hervonen A
Acta Neuropathol; 1996; 91(5):466-74. PubMed ID: 8740226
[TBL] [Abstract][Full Text] [Related]
13. Sympatholytic and minimum anesthetic concentration-sparing responses are preserved in rats rendered tolerant to the hypnotic and analgesic action of dexmedetomidine, a selective alpha(2)-adrenergic agonist.
Rabin BC; Reid K; Guo TZ; Gustafsson E; Zhang C; Maze M
Anesthesiology; 1996 Sep; 85(3):565-73. PubMed ID: 8853087
[TBL] [Abstract][Full Text] [Related]
14. Drugs acting at calcium channels can influence the hypnotic-anesthetic effect of dexmedetomidine.
Horváth G; Kovács M; Szikszay M; Benedek G
Acta Biochim Biophys Hung; 1991-1992; 26(1-4):75-81. PubMed ID: 1688240
[TBL] [Abstract][Full Text] [Related]
15. Role of serotonergic neurotransmission in the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist.
Rabin BC; Guo TZ; Gregg K; Maze M
Eur J Pharmacol; 1996 Jun; 306(1-3):51-9. PubMed ID: 8813614
[TBL] [Abstract][Full Text] [Related]
16. Chronic desipramine treatment desensitizes the rat to anesthetic and antinociceptive effects of the alpha2-adrenergic agonist dexmedetomidine.
Guo TZ; Reid K; Davies MF; Nacif-Coelho C; Rabin BC; Gonzalez F; Maze M
Anesthesiology; 1998 Jun; 88(6):1634-42. PubMed ID: 9637658
[TBL] [Abstract][Full Text] [Related]
17. Alpha2-adrenoceptor-independent inhibition of acetylcholine receptor channel and sodium channel by dexmedetomidine in rat superior cervical ganglion neurons.
Yang L; Tang J; Dong J; Zheng J
Neuroscience; 2015 Mar; 289():9-18. PubMed ID: 25583636
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine.
Doze V; Chen BX; Li Z; Maze M
Acta Vet Scand Suppl; 1989; 85():61-4. PubMed ID: 2571279
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole.
Hoffman WE; Kochs E; Werner C; Thomas C; Albrecht RF
Anesthesiology; 1991 Aug; 75(2):328-32. PubMed ID: 1677549
[TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine does not modify the neuromuscular blocking action of vecuronium in the anaesthetized rat.
Weinger MB; Partridge BL; Henry AF
Br J Anaesth; 1995 Apr; 74(4):455-7. PubMed ID: 7734268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
